Clinical Trials Directory

Trials / Unknown

UnknownNCT04229693

Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk

Proteomics of Cerebrospinal Fluid of Preterm Infants With Posthemorrhagic Hydrocephalus With Focus on Intranasal Breast Milk.

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
University Hospital of Cologne · Academic / Other
Sex
All
Age
3 Days – 12 Months
Healthy volunteers
Not accepted

Summary

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.

Detailed description

Since the nasal route might be highly effective for neurotrophins and other growth factors the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating effects of intranasal breast milk application on the cerebrospinal fluid proteom.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention, only observational.

Timeline

Start date
2020-02-07
Primary completion
2021-02-01
Completion
2021-08-01
First posted
2020-01-18
Last updated
2020-02-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04229693. Inclusion in this directory is not an endorsement.

Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk (NCT04229693) · Clinical Trials Directory